Apeloa CDMO is the contract manufacturing focused business of Apeloa, with strategically developed its business towards becoming one of the world's premier contract service organizations. Supported by a global network of manufacturing, development, and analytical facilities, Apeloa CDMO provides world-class discovery, development, and manufacturing services for Active Pharmaceutical Ingredients (APIs), Intermediates, and Registered Starting Materials (RSMs). The company's commitment to leading-edge science, best-in-class customer service, and regulatory compliance drives its success in the CDMO industry.

3 global R&D centers: ● Boston, USA --- Function in Q2 2024; 16,000 sq ft; 40+ chemists in two years; Tech Development Platform/Lead optimization/Screening/Tox Batch preparation ● Shanghai, China --- 68,000 sq ft; 300+ chemists; Screening/Process development/optimization/CMC ● Hengdian, China --- 88,000 sq ft; 250+ chemists; Process optimization/Tech transfer/CMC